REGENERATIVE THERAPIES FOR VULVAR LICHEN SCLEROSUS: A SYSTEMATIC REVIEW OF PLATELET-RICH PLASMA, EXOSOMES, AND ENERGY-BASED DEVICES
Keywords:
vulvar lichen sclerosus, platelet-rich plasma, PRP, exosomes, regenerative medicine, radiofrequency, Empower platform, vulvar aesthetiaesthetics.Abstract
Background: Vulvar lichen sclerosus (VLS) is a chronic inflammatory dermatosis that significantly affects female genital health, quality of life, and sexual function. Conventional treatment relies primarily on high-potency topical corticosteroids; however, recurrence and incomplete symptom control remain common. Regenerative medicine approaches, including platelet-rich plasma (PRP), exosome-based therapies, and energy-based devices, have emerged as potential alternatives or adjunctive treatments.
Objective: To systematically evaluate the available evidence regarding regenerative therapies for vulvar lichen sclerosus and to explore the potential role of combining biological therapies with energy-based technologies such as the Empower platform.
Methods: A systematic review was designed according to PRISMA 2020 recommendations. Relevant studies investigating PRP, exosomes, stem-cell-derived products, and energy-based devices for VLS were identified through electronic database searches. Eligible studies included clinical trials, observational studies, pilot investigations, and case series reporting therapeutic outcomes in women diagnosed with VLS.
Results: The available literature suggests that regenerative therapies may improve itching, pain, dyspareunia, tissue elasticity, and overall quality of life. PRP demonstrated the largest body of evidence among regenerative approaches, while exosome therapy remains an emerging field with limited clinical data. Energy-based devices showed promising results in tissue remodeling and symptom reduction. However, substantial heterogeneity exists regarding treatment protocols, outcome measures, and follow-up duration.
Conclusion: Regenerative therapies represent a promising direction in the management of VLS. Current evidence suggests potential benefits for symptom control and tissue restoration; however, high-quality randomized controlled trials are required before routine clinical implementation can be recommended.
References
Goldstein AT, King M, Runels C, Gloth M, Pfau R. Intradermal injection of autologous platelet-rich plasma for vulvar lichen sclerosus. J Am Acad Dermatol. 2019;80(6):1788-1790.
Franic D, Franic-Ivanisevic M. Platelet-rich plasma in vulvar lichen sclerosus treatment: preliminary outcomes. Eur J Obstet Gynecol Reprod Biol. 2018;224:99-104.
Tedesco G, Tamburro S, Ferrari F, et al. Platelet-rich plasma therapy in vulvar lichen sclerosus: clinical outcomes and patient satisfaction. Dermatol Ther. 2022;35(4):e15321.
Boero V, Brambilla L, Guanziroli E, et al. Regenerative approaches in vulvar lichen sclerosus. Int J Mol Sci. 2025;26(18):8808.
Medina Garrido JA, et al. Emerging therapies for vulvar lichen sclerosus. J Clin Med. 2023;12(15):4987.
Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487–514.
Casabona F, Priano V. Vulvar rejuvenation using autologous platelet-rich plasma. Aesthetic Plast Surg. 2017;41:296–303.
Behnia-Willison F, et al. Fractional CO2 laser for vulvovaginal disorders. Lasers Med Sci. 2017;32:201–209.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo